Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis-Reference-Cited by-同舟云学术

Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis

Published:2010-04 Issue:4 Volume:138 Page:1286-1296.e3
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Sandborn William J.,Korzenik Joshua,Lashner Bret,Leighton Jonathan A.,Mahadevan Uma,Marion James F.,Safdi Michael,Sninsky Charles A.,Patel Raman M.,Friedenberg Keith A.,Dunnmon Preston,Ramsey David,Kane Sunanda

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference37 articles.

1. Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis;Sandborn;Aliment Pharmacol Ther,2003

2. Oral 5-ASA therapy in ulcerative colitis: what are the implications of the new formulations?;Sandborn;J Clin Gastroenterol,2008

3. Salazopyrin, a new sulfanilamide preparation;Svartz;Acta Med Scand,1942

4. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype;Das;N Engl J Med,1973

5. Azodisal sodium in the treatment of ulcerative colitis;Sandberg-Gertzen;Gastroenterology,1986

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesalazine-induced myocarditis in a patient with ulcerative colitis: a case report;European Heart Journal - Case Reports;2024-08-27

3. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05

4. Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus;Journal of Clinical Medicine;2023-11-04

5. Safety Summary of Pediatric Inflammatory Bowel Disease Therapies;Gastroenterology Clinics of North America;2023-09